Trademarkia Logo

Australia

AU$
MODTYLSO
Cancelled: Cancelled at the request of IB

Last updated on 25 Jun 2024

Owner Info

Idera Pharmaceuticals, Inc.

505 Eagleview Blvd.

Exton PA 19341, UNITED STATES OF AMERICA

Serial Number

2160257 filed on 5 Jan 2021

Correspondent

Rebecca E. McDougall, Morgan, Lewis & Bockius LLP

1111 Pennsylvania Avenue, NW,

Washington DC 20004-2541,

UNITED STATES OF AMERICA

MODTYLSO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of advanced metastatic melanoma.

Mark Details


Serial Number

2160257

Registered On

5 Jan 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

8 Jul 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
25th Jun 2024Status change to Voided
27th May 2021International Registration in Australia Protected correspondence sent
26th May 2021IP Right Registration Published
26th May 2021Status change to Registered/Protected
20th Mar 2021Application Accepted correspondence sent
19th Mar 2021IP Right has been Examined
19th Mar 2021IP Right Acceptance Published
19th Mar 2021Status change to Accepted
4th Mar 2021Awaiting examination
4th Mar 2021Examination expedited